Rhizopus Nigricans Mold IgE Test

If your asthma never quite settles, your symptoms flare in damp rooms or around stored fruit and grain, and a standard allergy panel came back clean, this is the kind of test that can fill in the gap. Rhizopus nigricans is a black bread mold that grows on fruit, grains, soil, and damp indoor surfaces, and it is rarely included in routine allergy testing.

Measuring IgE (immunoglobulin E, the antibody class behind classic allergic reactions) against this mold tells you whether your immune system has built a specific allergic response to it. In one study of children with allergic asthma in Southwest China, more than two thirds were sensitized to this mold while none of the healthy controls were, which is the kind of signal that suggests the test is worth running when conventional allergy panels do not explain the symptoms.

What This Test Reveals

Rhizopus nigricans IgE is a serum (blood) antibody made by your B cells, the white blood cells that produce antibodies. A positive result means your immune system has recognized proteins from this mold as a threat and built an IgE response to them. That same response is what triggers asthma flares, hives, sinus inflammation, and nasal symptoms when you encounter the mold again.

Most IgE in your body is bound to mast cells and basophils (the cells that release histamine during an allergic reaction), so blood tests only capture the small fraction of IgE circulating freely in serum. A positive result confirms sensitization, meaning your immune system has the machinery to react. Whether that sensitization translates into symptoms depends on your exposure level, your overall allergic burden, and your other clinical findings.

Asthma in Children and Adults

The strongest human evidence for this test comes from asthma. In a study of 301 people in Southwest China, 67.3% of children with allergic asthma were sensitized to Rhizopus nigricans, compared with 0% of 20 healthy controls. Sensitized children had higher blood eosinophils, higher exhaled nitric oxide (a marker of airway inflammation), and worse asthma control scores than children without this sensitization.

In Finnish schoolchildren the picture was different but pointed in the same direction. Mold-specific IgE was uncommon overall, but among the children who did have it, almost all were asthmatic or wheezing boys exposed to indoor dampness. One child in this kind of pattern had been labeled as having nonallergic asthma after a 19-allergen panel came back negative, and was only later identified as Rhizopus-sensitized once mold testing was added.

Occupational and Environmental Exposure

People who breathe in mold-heavy air at work develop this antibody much more often than the general population. Among tobacco-processing workers, 51.5% had detectable Rhizopus nigricans IgE, and they had more respiratory symptoms, more nasal symptoms, and lower lung function than less-exposed workers. A coal miner with persistent occupational asthma was found to have clear sensitization to this mold growing in the mine environment, and his symptoms tracked closely with his exposure.

Indoor exposure matters too. Damp homes, water-damaged buildings, and food storage areas (especially with overripe fruit, grains, and root vegetables) are all common reservoirs. If your symptoms cluster around specific environments, this antibody is one of the more direct ways to confirm whether the mold in those spaces is actually triggering your immune system.

Allergic Bronchopulmonary Mycosis

In rare cases, a Rhizopus IgE response progresses into allergic bronchopulmonary mycosis, an asthma-like illness driven by an allergic reaction to a mold colonizing the airways. Two siblings, one with cystic fibrosis and one without, developed severe asthma-like disease and very high total IgE that was eventually traced to Rhizopus nigricans. Both improved with systemic steroids, the IgE-blocking biologic omalizumab, and mold avoidance once the right allergen was identified.

International ABPA/ABPM (allergic bronchopulmonary aspergillosis and mycosis) guidelines now recommend screening for fungus-specific IgE in newly diagnosed asthmatic adults at tertiary care and in difficult-to-treat asthmatic children, and considering ABPM in patients with an ABPA-like presentation but negative standard Aspergillus testing. In cystic fibrosis specifically, adding mold-specific IgE for non-Aspergillus species (with total IgE at or above 417 IU/mL) helped identify additional cases of allergic bronchopulmonary mycosis that standard criteria would have missed.

Reference Ranges

Rhizopus nigricans IgE is a research and specialty marker, not a standardized clinical test with universally accepted cutpoints. The thresholds below come from published research using enzyme-immunoassay platforms in pediatric and asthma populations. They are illustrative orientation, not a target. Your lab will likely report different numbers and may use different units.

Source: cutpoints based on Taskinen et al. (Finnish schoolchildren, n=341 with skin testing, n=93 with IgE measurement) and Fang et al. (asthmatic children in Southwest China, n=301). Compare your results within the same lab over time for the most meaningful trend.

Why a Single Reading Can Fool You

Specific IgE numbers should always be interpreted alongside symptoms, exposure history, and other allergic markers. A positive result confirms sensitization but does not prove that this mold is actually causing your symptoms, and a negative result in isolation does not fully rule it out, particularly if total IgE is high or other fungal IgEs are positive. Cross-reactivity is common in the mold family, so a positive Rhizopus result may partly reflect sensitization to related species.

• Demographic patterns: total IgE peaks in childhood and tends to be lower in females, which can shift specific IgE results without changing the underlying allergy.
• Seasonal variation: environmental mold exposure peaks in spring and early summer in many climates, and symptoms can flare even when the IgE number itself looks unremarkable.
• Cross-reactivity: mold-allergic individuals often react to multiple fungi at once because of shared protein structures, so this number rarely stands alone.
• Standard panels can miss it: Rhizopus nigricans is not in most routine allergy panels, so a clean standard panel does not exclude this sensitization.

Tracking Your Trend

Specific IgE levels are not static. They reflect both the immune system's existing memory and your ongoing exposure. Levels can rise during heavy mold exposure (a damp home, a moldy workplace, a season of high outdoor mold counts) and may fall when exposure is reduced or after sustained anti-allergic treatment. A single reading tells you whether sensitization exists at this moment. A trend over time tells you whether your environment, treatment, and immune response are moving in the right direction.

Get a baseline reading. If you are positive and making changes (mold remediation at home, leaving a high-exposure job, starting a biologic like omalizumab), retest in 3 to 6 months. Once levels stabilize, annual testing is reasonable, especially if you remain symptomatic or live or work in a damp environment. Pair the trend with a symptom diary so you can correlate antibody levels with how you actually feel.

What to Do With an Abnormal Result

A positive Rhizopus nigricans IgE alone does not dictate a single action. The result becomes useful when combined with other tests and a clinical picture. If your result is positive, the practical next steps depend on the pattern.

• Pair it with total IgE, blood eosinophils, and other mold-specific IgEs: this tells you whether you have isolated Rhizopus sensitization or a broader fungal-allergic profile.
• Get an exposure assessment: look for visible mold, water damage, and dampness at home and at work. The case literature is full of people whose results normalized clinically only after the source was found.
• See an allergist or pulmonologist if you have asthma: if your asthma is poorly controlled despite standard inhalers, fungal sensitization is a recognized phenotype that may respond to anti-IgE biologics or antifungal therapy under specialist care.
• Consider ABPM workup if total IgE is very high: very elevated total IgE alongside positive mold-specific IgE, especially with airway symptoms or imaging findings, warrants a structured workup for allergic bronchopulmonary mycosis.